Infections in recipients of kidney transplants

Infectious Disease Clinics of North America

Volumn 15, Issue 3, 2001, Pages 901-952

  Patel, Robin ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; GRAFT INFECTION; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MYCOSIS; PARASITOSIS; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; RECIPIENT; REVIEW; VIRUS INFECTION;

EID: 0034850814     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70178-1     Document Type: Article

References (286)

1. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation
2. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients
3. Peliosis hepatis due to Bartonella henselae in transplantation: A hemato-hepato-renal syndrome
4. Emphysematous cystitis and pyelitis in a diabetic renal transplant recipient
5. Legionella infection in transplant patients
6. Targeted tuberculin testing and treatment of latent tuberculosis infection
7. Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B
8. Isoniazid hepatotoxicity in renal transplant recipients
9. Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine
10. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients
11. Infections and immunizations in organ transplant recipients: A preventive approach
12. Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients
13. A randomized placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts
14. Cytomegalovirus vaccine in renal transplant candidates: Progress report of a randomized, placebo-controlled, double-blind trial
15. Cytomegalovirus vaccine trial in 400 renal transplant candidates
16. Results of renal transplantation in patients with Schistosoma infection
17. Visceral leishmaniasis (kala-azar) in transplant recipients: Case report and review
18. High prevalence of hepatitis G virus (HGV) infection in renal transplantation
19. Membranoproliferative glomerulonephritis with subendothelial deposits (type 1) associated with hepatitis G virus infection in a renal transplant recipient
20. Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients
21. Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: An underestimated infectious disease in the immunocompromised host
22. Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection
23. Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in renal transplant recipient
24. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss
25. Hepatitis C infection in patients with hypogamma-globulinemia after treatment with contaminated immune globulin
26. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: Report on three cases and review of the literature
27. Congenital cytomegalovirus infection after recurrent infection in a mother with a renal transplant
28. Evaluation of a new method for early detection of active cytomegalovirus infections. A study in kidney transplant recipients
29. Transmission of human immunodeficiency virus (HIV) by transplantation: Clinical aspects and time course analysis of viral antigenemia and antibody production
30. Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine
31. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients
32. Varicella and zoster in children after kidney transplantation: Long-term results of vaccination
33. Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C
34. Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function
35. Immunization of pediatric solid organ transplant candidates and recipients
36. Disseminated inoculation blastomycosis in a renal transplant recipient
37. Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation
38. Bacillary angiomatosis in a renal transplant recipient
39. Coccidioidomycosis in renal replacement therapy
40. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients
41. Mycobacterium chelonae: A cause of nodular skin lesions with a proclivity for renal transplant recipients
42. Mycobacterial infections in recipients of kidney allografts. A seventeen-year experience
43. Epstein-Barr virus surveillance after renal transplantation
44. Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts
45. Cerebral toxoplasmosis after renal transplantation. Case report and review
46. The impact of azathioprine on chronic viral hepatitis in renal transplantation: A long-term, single-center, prospective study on azathioprine withdrawal
47. Disseminated histoplasmosis in renal transplant recipients
48. Hepatitis B and transplantation
49. Subclinical pneumonitis during cytomegalovirus infection after kidney transplantation
50. Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection
51. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection
52. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection
53. Cytomegalovirus-induced necrotizing and crescentic glomerulonephritis in a renal transplant patient
54. Disseminated strongyloidiasis complicating acute renal allograft rejection. Prolonged thiabendazole administration and successful retransplantation
55. Opportunistic infections with Strongyloides stercoralis in renal transplantation
56. Non-typhoid Salmonella in renal transplant recipients; a report of twenty cases and review of the literature
57. Human polyoma virus in renal allograft biopsies: Morphological findings and correlation with urine cytology
58. Is cytomegalovirus a cause of ureteral stricture in renal transplant recipients?
59. Early infections in kidney, heart, and liver transplant recipients on cyclosporine
60. Antimicrobial chemotherapy for Legionnaires disease: Time for a change
61. Effectiveness of low dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation
62. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
63. Human immunodeficiency virus infection in patients with solid-organ transplants: Report of five cases and review
64. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients
65. Phaeohyphomycotic soft tissue disease caused by Pleurophomopsis lignicola in a kidney transplant patient
66. Mycobacterium marinum infection in a renal transplant recipient
67. Transmission of Chagas' disease through transplanted kidney: Occurrence of the acute form of the disease in two recipients from the same donor
68. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients
69. Monitoring of CMV infection after renal transplantation: Serology, culture, and viral DNA detection by hybrid capture
70. HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients
71. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: Clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis
72. Disseminated Mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft
73. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients
74. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation
75. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus
76. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial
77. Herpes simplex virus encephalitis in a renal transplant patient: Diagnosis by polymerase chain reaction detection of HSV DNA
78. Lack of graft rejection in a renal transplant recipient with AIDS
79. Acyclovir prophylaxis for cytomegalovirus disease in high-risk renal transplant recipients: Is it effective?
80. Primary Epstein-Barr virus infection in a renal transplant recipient
81. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
82. Fatal case of Trichoderma harzianum infection in a renal transplant recipient
83. Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil
84. Invasive aspergillosis after transplantation
85. Autosomal dominant polycystic kidney disease in a kidney transplant population
86. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection
87. Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon
88. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years
89. Pretransplant hepatitis C virus infection: A predictor of proteinuria after renal transplantation
90. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial
91. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation
92. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: Treatment with voriconazole
93. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients
94. Fungal infections in renal transplant recipients
95. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients
96. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor
97. Salmonella infection in renal transplant recipients
98. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: Clinical course and successful treatment for late acute rejection induced by interferon therapy
99. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients
100. Failure of ganciclovir prophylaxis to completely eradicate CMV disease in renal transplant recipients treated with intense anti-rejection immunotherapy
101. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients
102. Epstein-Barr virus-associated Hodgkin's disease following renal transplantation
103. Cutaneous infection due to Cladophialophora bantiana in a patient receiving immunosuppressive therapy
104. Influence of anti-rejection therapy on the timing of cytomegalovirus disease and other infections in renal transplant recipients
105. Subcutaneous phaeohyphomycosis in a renal transplant recipient: A case report and review of the literature
106. Laryngeal tuberculosis in renal transplant recipients
107. Irreversible glomerular lesions induced by crystal precipitation in a renal transplant after foscarnet therapy for cytomegalovirus infection
108. Fatal hepatitis B virus infection with fibrosing cholestatic hepatitis following renal transplantation
109. Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain
110. For the American Society for Transplantation: Recommendations for the outpatient surveillance of renal transplant recipients
111. Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: Effect of acute rejection
112. Prospective study of human betaherpesviruses after renal transplantation - Association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection
113. Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR 3 as a risk factor for the development of posttransplant hepatitis
114. Mycobacterium tuberculosis infection of a native polycystic kidney following renal transplantation
115. Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients
116. An outbreak of Legionelia micdadei pneumonia in transplant patients: Evaluation, molecular epidemiology, and control
117. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients
118. Cryptococcosis in a renal unit
119. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome
120. Risk factors for nosocomial urinary tract and postoperative wound infections in renal transplant patients: A matched-pair case-control study
121. Cystic smooth-muscle tumor of the liver and spleen associated with Epstein-Barr virus after renal transplantation
122. Epidemic of nosocomial Legionnaires' disease in renal transplant recipients: A case-control and environmental study
123. Strongyloides stercoralis in chronic renal failure: Safe therapy with thiabendazole
124. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: A distinct entity?
125. Papillomavirus in urine in pregnancy and following renal transplantation
126. Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant
127. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
128. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients
129. Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy
130. Transmission of Histoplasma capsulatum by organ transplantation
131. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections
132. Varicella-zoster infection in cyclosporine A-treated renal transplant patients
133. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation
134. A longitudinal study of varicella-zoster virus infections in renal transplant recipients
135. Mycobacterial infection complicating renal transplantation
136. Varicella in pediatric renal transplant recipients
137. Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil
138. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine
139. Hepatitis C virus infections in transplant patients: Serological and virological investigations
140. Human parvovirus B19 infection in organ transplant recipients
141. Cytomegalovirus vaccine in renal allograft recipients
142. Nonfatal gastric mucormycosis in a renal transplant recipient
143. Chronic anemia as a complication of parvovirus B19 infection in a pediatric kidney transplant patient
144. An interesting case of failed renal transplant complicated by a lymphocele infected with Pasteurella multocida and a review of the literature
145. Progressive multifocal leukoencephalopathy in renal transplant recipients
146. Idiopathic thrombocytopenia after cytomegalovirus infection in a renal transplant recipient
147. Phaeohyphomycosis in kidney transplant patients
148. A case of Enterocytozoon bieneusi infection in an HIV-negative renal transplant recipient
149. Routine perioperative antibiotic prophylaxis in renal transplantation
150. Bacteremia among kidney transplant recipients: A case-control study of risk factors and short-term outcomes
151. Respiratory syncytial virus infections in pediatric renal transplant recipients
152. Immunosuppression and circulating Trypanosoma cruzi in a kidney transplant recipient
153. Hepatitis C virus infection and renal transplantation
154. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation
155. Opportunistic strongyloidiasis in renal transplant recipients
156. Ureteritis and cholecystitis: Two unusual manifestations of cytomegalovirus disease in renal transplant recipients
157. Parvovirus B19 infection-related complications in renal transplant recipients: Treatment with intravenous immunoglobulin
158. Transmission of Mycobacterium tuberculosis with renal allografts
159. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients
160. Cerebral tuberculoma 11 years after renal transplantation
161. Isolated cerebral aspergilloma - Long-term survival of a renal transplant recipient
162. Ischemic colitis secondary to venous thrombosis. A rare presentation of cytomegalovirus vasculitis following renal transplantation
163. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients
164. Central nervous system infection with Listeria monocytogenes, 33 years' experience at a general hospital and review of 776 episodes from the literature
165. Pyelonephritis and vesicoureteral reflux after renal transplantation in young children
166. Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir
167. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease
168. BK-virus nephropathy in renal transplants - Tubular necrosis, MHC-class II expression and rejection in a puzzling game
169. Listeria encephalitis in five renal transplant recipients
170. Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis
171. Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
172. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment
173. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients
174. Streptococcus mitis urinary tract infection in a renal transplant patient
175. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients
176. Human polyoma virus infection of renal allografts: Histopathologic diagnosis, clinical significance, and literature review
177. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant
178. Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients
179. Optimization of the detection of cytomegalovirus viremia by shell vial in transplantation recipients
180. Infections in solid-organ transplant recipients
181. Infections due to nontuberculous mycobacteriain kidney, heart, and liver transplant recipients
182. Disseminated histoplasmosis in renal allograft recipients
183. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease
184. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients
185. Continuous sulfa prophylaxis for urinary tract infection in renal transplant recipients
186. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants
187. Cytomegalovirus vaccine virus (Towne strain) does not induce latency
188. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant
189. CMV infection is associated with transplant renal artery stenosis
190. Legionella pneumonia in transplant recipients: A cluster of cases of eight years' duration
191. Urinary tract infection caused by Hansenula anomala
192. Report of 24 cases of Listeria monocytogenes infection at the University of Miami Medical Center
193. Mycobacterial infection after renal transplantation: Report of 14 cases and review of the literature
194. Human polyoma virus-associated interstitial nephritis in the allograft kidney
195. Nocardiosis in a recently transplanted renal patient
196. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients
197. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load
198. Two cases of progressive multifocal leukoencephalopathy after renal transplantation
199. HIV infection in kidney transplant recipients
200. Glomerulopathy associated with cytomegalovirus viremia in renal allografts
201. Increased levels of circulating Epstein-Barr virus EBV-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients
202. Fatal disseminated Nocardia farcinica infection in a renal transplant recipient
203. Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients
204. Interactions of cytomegalovirus with the human immune system
205. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation
206. Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients
207. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: Correlation with clinicopathological features
208. Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil
209. Antimicrobial strategies in the care of organ transplant recipients
210. Nocardial brain abscess in a renal transplant recipient successfully treated with triple antimicrobials
211. Epstein-Barr virus-associated post-transplant primary smooth muscle tumor of the liver: Report of an autopsy case
212. The high incidence of tuberculosis among renal transplant recipients in India
213. Multiple Cladosporium brain abscesses in a renal transplant patient: Aggressive management improves outcome
214. Protective effect of cyclosporine in human renal posttransplant cryptococcosis
215. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant recipients
216. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study
217. Phaeohyphomycosis from Exphiala jeanselmei with concomitant Nocardia asteroides infection in a renal transplant recipient: Case report and review of the literature
218. Tuberculosis in renal transplant recipients
219. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients
220. Listeria monocytogenes infection after renal transplantation
221. Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients
222. Blastomycosis in transplant recipients: Report of a case and review
223. Cryptococcosis in renal transplant recipients
224. Human herpes virus 8 infection in kidney transplant patients in Belgium
225. A giant gastric ulcer caused by mucormycosis infection in a patient with renal transplantation
226. Paracoccidioidomycosis in a renal transplant recipient
227. Cytomegalovirus involving gastrointestinal tract in renal transplant recipients
228. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients
229. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor
230. Invasive mycoses in organ transplant recipients: Controversies in prophylaxis and management
231. Invasive gastrointestinal zygomycosis in a liver transplant recipient: Case report and review of zygomycosis in solid-organ transplant recipients
232. Significant bacteriuria in renal transplant recipients
233. Mycobacterial infections in the transplant patient
234. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients
235. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group
236. Successful treatment of infection due to Mycoplasma hominis with streptogramins in a renal transplant patient: Case report and review
237. Relative risk of donor-transmitted Toxoplasma gondii infection in heart, liver and kidney transplant recipients
238. Pentamidine inhalation as a prophylaxis against Pneumocystis carinii pneumonia after therapy of acute renal allograft rejection with orthoclone (OKT3)
239. Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S. transplant centers
240. Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host
241. Posttransplant lymphoproliferative disorder in pediatric renal transplantation
242. Listeriosis in renal transplant recipients: Report of an outbreak and review of 102 cases
243. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient
244. Paracoccidioidomycosis in the immunosuppressed host: Report of a case and review of the literature
245. A tuberculosis outbreak in a renal transplant program
246. Clinicopathologic aspects of 8 Kaposi's sarcomas among 1009 renal transplant patients
247. Increasing incidence of Pneumocystis carinii pneumonia in renal transplant recipients
248. Hepatitis C infection in the transplant recipient
249. Management of herpes virus infections following transplantation
250. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients
251. Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic
252. Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation
253. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients
254. Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction
255. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: Response to interferon-alpha therapy
256. Posttransplant malaria
257. Acute hemorrhagic cystitis by adenovirus type 11 with and without type 37 after kidney transplantation
258. Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients
259. Relapsing tinea capitis by Microsporum canis in an adult female renal transplant recipient
260. Prevalence of superficial dermatomycoses in 73 renal transplant recipients
261. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients
262. De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection
263. Pretransplantation assessment of the risk of lymphoproliferative disorder
264. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations
265. Cure of cryptococcal infection during continued immunosuppressive therapy
266. Aspergillosis in 25 renal transplant patients
267. Strongyloides stercoralis infection in renal transplant recipients
268. Clostridium difficile colitis after kidney and kidney-pancreas transplantation
269. Invasive pulmonary aspergillosis in the early postcardiac transplantation period
270. Histoplasmosis in renal allograft recipients. Two large urban outbreaks
271. Nocardial infections in renal transplant recipients
272. Gastric mucormycosis due to Rhizopus oryzae in a renal transplant recipient
273. Hyperimmune globulin prophylaxis for cytomegalovirus infection in renal transplantation
274. Cytomegalovirus-induced tubulointerstitial nephritis in a renal allograft treated by foscarnet therapy
275. Failure of acyclovir to prevent cytomegalovirus infection in renal allograft recipients
276. Parvovirus B 19 infection causing red cell aplasia in renal transplantation on tacrolimus
277. Interferon-α therapy for hepatitis C infection after liver transplantation
278. The evaluation and management of urinary tract infections in recipients of solid-organ transplants
279. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era
280. Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey
281. Tuberculosis after renal transplantation: Experience of one Turkish centre
282. Coccidioidomycosis in renal dialysis and transplant patients: Radiologic findings in 30 patients
283. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years
284. Attenuated varicella virus vaccine in children with renal transplantation
285. Foscarnet-induced crystalline glomerulonephritis with nephrotic syndrome and acute renal failure after kidney transplantation
286. Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation